Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods to suppress an immune response with variant CD44-specific antibodies

Methods to suppress an immune response with variant CD44-specific antibodies

US Patent 5951982 · Granted Sep 14, 1999

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CD44v6-derived peptides for treating metastasizing cancer2017
CD44v6-derived peptides for treating pancreatic cancer2017
CD44V6-derived peptides for treating breast cancer2017
CD44V6 peptides as inhibitors of bacterial infections2015
Use of a peptide fragment of CD44v6 in the treatment of ophthalmic diseases2014
Valproic acid and derivatives thereof as histone deacetylase inhibitors2007
Agent for identifying and treating metastasizing tumors2002
Agent for identifying and treating metastasizing tumors2002
Process for detecting a variant CD44 gene product2000
Process for detecting a variant CD44 gene product2000
Antibodies that react with variant CD44 surface proteins1999
Antibodies that react with variant CD44 surface proteins1999